Many regular users will at some point have experienced feelings of sleepiness and lethargy after using cannabis. This effect varies between individuals, and an individual may find themselves differently affected according to mood, existing tiredness, or even time of day. The variety of cannabis also has a major part to play.
In the second part of "Cannabis: a plant with many faces", we present three people who use medicinal cannabis due to their multiple ailments as well as their quite complex medical conditions. Read their stories for yourself...
In Germany, the death of Robert Strauss has hit the headlines in recent weeks, even giving a little impetus to the discussion on medicinal cannabis. A person had to die for the issue to be considered again. Read on...
Chronic migraine is a painful and debilitating condition that affects up to 5% of people worldwide. The biological mechanism behind migraine is still not fully understood, but it is known to be fundamentally associated with serotonin signalling. Cannabis, which also affects the serotonin system, has been shown to reduce symptoms.
Alzheimer’s is a progressive neurodegenerative disease that typically presents in adults over the age of 65. The disease causes symptoms such as dementia; as it progresses, it renders the sufferer increasingly unable to care for themselves. There is no cure for Alzheimer’s, but medications such as cannabis may slow its progression.
All good things come to an end, which also counts for this chapter of SensiBilisation with Professor Raphael Mechoulam. But we saved the best for last! In this episode Professor Mechoulam reveals something he has never shared in front of a camera before in such great detail: his own personal experiences with THC.
Cannabis is famed for causing uncontrollable laughter or “fits of the giggles” in users. Many intoxicating substances can elicit mood changes in users, such as alcohol and various hallucinogens and opiates. The “positive” changes in mood often include feelings of profound joy, pleasure and exhilaration—and an increased propensity for laughter. Historically, many of the dozens of papers that note the phenomenon have simply mentioned its existence without exploring the mechanisms at work too closely. However, now that our approach to understanding psychological processes has matured somewhat, researchers are beginning to pay closer attention to the processes at work when humans use psychoactive drugs, and assessing their potential to improve mood—particularly in depressed or otherwise psychologically-unbalanced individuals.
There are hundreds, if not thousands of books on cannabis available today, ranging from sensationalist to serious and scholarly. For even the most discerning readers, it can be difficult to assess the quality of publications prior to purchase. Therefore, we have provided a short list of recommended books on medical cannabis.
Years ago Professor Raphael Mechoulam researched terpenes. These are non-active compounds in cannabis which also can be found in many other plants. He found out that they influence the activity of other compounds in cannabis, such as THC and CDB. In this episode the Professor points out the importance of terpenes in cannabis.
In Germany, over 320,000 people suffer from a form of inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, which are the most common. Cannabis can contribute to easing the symptoms of Crohn's disease, as Marco's story shows.
A moving and revelatory talk on the impact of high CBD medicinal cannabis oil on the lives of Hugh Hempel and his family. His twin daughters suffer from Niemann Pick Type C, often referred to as “Childhood Alzheimer’s.” Since the 2006 diagnosis, Hugh and his wife Chris have been researching new methods of treatment for this rare and fatal neurodegenerative disease.
In 1964 Professor Raphael Mechoulam and his team of researchers discovered and isolated tetrahydrocannabinol (THC) – the main psychoactive ingredient in cannabis - for the very first time. Many discoveries on the medicinal value of cannabinoids have been made ever since, but the Professor believes there is still much more to discover
The ability of cannabis to improve the symptoms of glaucoma has been demonstrated in various studies, but doubts still remain over its efficacy and consistency within patient populations. Despite this, many medical cannabis patients utilize cannabis for glaucoma, and report subjective improvements in various symptoms.
Raphael Mechoulam is making a clear statement in this fourth SensiBilisation episode with the THC-Professor. Mechoulam states that if cannabis treatments are not quantitative, then physicians will not accept them. The Professor is using some very strong examples to underline this statement. Do you agree or disagree with Raphael Mechoulam? Share your thoughts in the comments below.
Cannabis is infamous for causing ravenous hunger. This is so well-known that it is an integral aspect of the mainstream media’s “stoner stereotype”—the red-eyed, indolent (and usually male) twenty-something who plays video games all day and is never without a bag of Cheetos. Here, we attempt to explain this complex phenomenon.
The Brazilian National Health Surveillance Agency has authorized the use of cannabidiol to treat severe seizures. South America has taken another step forward on the path to legal cannabis as Brazil reclassified cannabidiol (CBD) as “controlled” rather than illegal.
??In the third episode of SensiBilisation featuring Raphael Mechoulam, the Professor indicates that sometimes science misses out on certain discoveries. As an example, Mechoulam uses anandamide, a very simple but important compound that only was discovered in 1992.
Epilepsy refers to a group of conditions characterised by recurrent seizures, which may be convulsive or non-convulsive. Cannabis and cannabis-based therapies have been shown to have beneficial effects on several types of epilepsy, through a variety of biological mechanisms.
Parkinson’s disease is a degenerative disorder, which affects the central nervous system by causing the destruction of the dopamine-producing cells in an area of the brain known as the substantia nigra. The motor functions are first to be affected; as it progresses, cognitive decline, dementia and depression can take hold.